Medpace (NASDAQ:MEDP) is a full-service clinical contract research organization (CRO) that serves the pharmaceutical, biotechnology, and medical device industries. With a global reach and a comprehensive suite of services, Medpace is committed to accelerating the development of safe and effective medical therapies. The company specializes in the management of clinical trials from protocol development through to FDA or EMA submission. Their expertise spans across multiple therapeutic areas, including oncology, cardiovascular, metabolic diseases, and more. Medpace’s objective is to support its clients in bringing innovative treatments to market as efficiently and effectively as possible, ensuring the highest standards of clinical research are maintained.